Insider filing · CORT
Atabak Mokari
Chief Financial Officer
profile →
Corcept Therapeutics Incorporated
CORT · Healthcare · 106 filings in 24 months
ticker →
Atabak Mokari sold $2.8M of Corcept Therapeutics Incorporated (CORT)
Executed Jun 1, disclosed Jun 3, 2 days later.
Value, as filed
$2.8M
40,000 sh × $70.00
Executed
Jun 1
the trade date, as filed
Disclosed
Jun 3
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
AMAtabak Mokari (Chief Financial Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Corcept Therapeutics Incorporated (CORT). The largest single filing was $9.1M of CORT (79,000 sh across 11 lots, as filed), executed Jul 30.
The name
CORTHealthcare · Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe end…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Atabak Mokari in CORT
CORTSALE
Corcept Therapeutics Incorporated
$9.1M79,000 sh across 11 lots
Exec Jul 30
Filed Aug 3 · 4:30 PM ET CORTSALE Corcept Therapeutics Incorporated $3.5M
39,899 sh across 3 lots
Exec Jul 15
Filed Jul 17 · 6:31 PM ET CORTSALE Corcept Therapeutics Incorporated $3.2M
39,998 sh across 3 lots
Exec Jun 15
Filed Jun 17 · 5:30 PM ET